Several upregulated pathways, including the ECM–receptor interaction and the IL-17 signaling pathway, were simultaneously enriched in C3 and SPP1+ macrophages; therefore, C3 was assumed as an SPP1+ macrophage-associated HCC subtype. The gene discussed is IL17A; the disease is hepatocellular carcinoma.